Abstract
Traditional cancer treatments have disadvantages of large trauma area and toxic side effects while killing cancer cells. Peptide-targeted sonodynamic therapy (SDT) can effectively improve specificity of cancer treatment and overcome the problem of low tissue penetration depth caused by a photo-driven therapy. Herein, we developed a porphyrin-based sonosensitizer with a water-soluble polymer as a biological carrier and a cRGD peptide for tumor targeting, which constituted a nano sonosensitizer (T-cRGD NPs) for fluorescence imaging-guided sonodynamic therapy. A comparable sonosensitizer (T-PEG NPs) without the targeting unit was also prepared for illustration of therapeutic performance. Attribute to the role of peptide targeting, T-cRGD NPs can accumulate and enter tumor cells for fluorescence imaging and show a superior SDT effect than T-PEG NPs in vitro. The imaging in vivo reveals that T-cRGD NPs can enrich in tumor tissues within 14 h with a good biocompatibility.
Similar content being viewed by others
References
Behin, A.; Hoang-Xuan, K.; Carpentier, A. F.; Delattre, J. Y. Primary brain tumours in adults. The Lancet 2003, 361, 323–331.
Sharma, G. N.; Dave, R.; Sanadya, J.; Sharma, P.; Sharma, K. K. Various types and management of breast cancer: an overview. J. Adv. Pharm. Technol. Res. 2010, 1, 109–126.
Didkowska, J.; Wojciechowska, U.; Mańczuk, M.; Łobaszewski, J. Lung cancer epidemiology: contemporary and future challenges worldwide. Ann. Transl. Med. 2016, 4, 150–150.
Schirrmacher, V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int. J. Oncol. 2019, 54, 407–419.
Zheng, X.; Bian, S.; Liu, W.; Zhang, C.; Wu, J.; Ren, H.; Zhang, W.; Lee, C. S.; Wang, P. Amphiphilic diketopyrrolopyrrole derivatives for efficient near-infrared fluorescence imaging and photothermal therapy. ACS Omega 2021, 6, 26575–26582.
Moan, J.; Peng, Q. An outline of the history of PDT. Anticancer Res. 2003, 23, 3591–3600.
Park, W.; Cho, S.; Han, J.; Shin, H.; Na, K.; Lee, B.; Kim, D.-H. Advanced smart-photosensitizers for more effective cancer treatment. Biomater. Sci. 2018, 6, 79–90.
Jin, J.; Zhu, Y.; Zhang, Z.; Zhang, W. Enhancing the efficacy of photodynamic therapy through a porphyrin/POSS alternating copolymer. Angew. Chem. Int. Ed. 2018, 57, 16354–16358.
Zheng, X.; Liu, W.; Ge, J.; Jia, Q.; Nan, F.; Ding, Y.; Wu, J.; Zhang, W.; Lee, C. S.; Wang, P. Biodegradable natural product-based nanoparticles for near-infrared fluorescence imaging-guided sonodynamic therapy. ACS Appl. Mater. Interfaces 2019, 11, 18178–18185.
Kim, H. M.; Cho, B. R. Small-molecule two-photon probes for bioimaging applications. Chem. Rev. 2015, 115, 5014–5055.
Jin, G.; He, R.; Liu, Q.; Lin, M.; Dong, Y.; Li, K.; Tang, B. Z.; Liu, B.; Xu, F. Near-infrared light-regulated cancer theranostic nanoplatform based on aggregation-induced emission luminogen encapsulated upconversion nanoparticles. Theranostics 2019, 9, 246–264.
Umemura, S. I.; Yumita, N.; Nishigaki, R.; Umemura, K. Sonochemical activation of hematoporphyrin: a potential modality for cancer treatment. Ultrason. Sympos. Proceed. 1989, 2, 955–960.
Yumita, N.; Nishigaki, R.; Umemura, K.; Umemura, S. I. Synergistic Effect of Ultrasound and Hematoporphyrin on Sarcoma. Jap. J. Cancer Res. 1990, 81, 304–308.
Son, S.; Kim, J. H.; Wang, X.; Zhang, C.; Yoon, S. A.; Shin, J.; Sharma, A.; Lee, M. H.; Cheng, L.; Wu, J.; Kim, J. S. Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem. Soc. Rev. 2020, 49, 3244–3261.
Canavese, G.; Ancona, A.; Racca, L.; Canta, M.; Dumontel, B.; Barbaresco, F.; Limongi, T.; Cauda, V. Nanoparticle-assisted ultrasound: a special focus on sonodynamic therapy against cancer. Chem. Eng. J. 2018, 340, 155–172.
Hoogenboom, M.; Eikelenboom, D.; den Brok, M. H.; Heerschap, A.; Fütterer, J. J.; Adema, G. J. Mechanical high-intensity focused ultrasound destruction of soft tissue: working mechanisms and physiologic effects. Ultrasound Med. Biol. 2015, 41, 1500–1517.
Choi, V.; Rajora, M.; Zheng, G. Activating drugs with sound: mechanisms behind sonodynamic therapy and the role of nanomedicine. Bioconjug. Chem. 2020, 31, 967–989.
Lin, X.; Song, J.; Chen, X.; Yang, H. Ultrasound-activated sensitizers and applications. Angew. Chem. Int. Ed. 2020, 59, 14212–14233.
Yumita, N.; Sakata, I.; Nakajima, S.; Umemura, S. I. Ultrasonically induced cell damage and active oxygen generation by 4-formyloximeetylidene-3-hydroxyl-2-vinyl-deuterio-porphynyl(IX)-6–7-diaspartic acid: on the mechanism of sonodynamic activation. Biochim. Biophys. Acta 2003, 1620, 179–184.
Yumita, N.; Kawabata, K. I.; Sasaki, K.; Umemura, S. I. Sonodynamic effect of erythrosin B on sarcoma 180 cells in vitro. Ultrason. Sonochem. 2002, 9, 259–265.
An, R.; Cheng, X.; Wei, S.; Hu, Y.; Sun, Y.; Huang, Z.; Chen, H. Y.; Ye, D. Smart magnetic and fluorogenic photosensitizer nanoassemblies enable redox-driven disassembly for photodynamic therapy. Angew. Chem. Int. Ed. 2020, 59, 20636–20644.
Zhang, C.; Wu, J.; Liu, W.; Zheng, X.; Zhang, W.; Lee, C. S.; Wang, P. Hypocrellin-based multifunctional phototheranostic agent for NIR-triggered targeted chemo/photodynamic/photothermal synergistic therapy against glioblastoma. ACS Appl. Bio Mater. 2020, 3, 3817–3826.
Huveneers, S.; Truong, H.; Danen, E. H. J. Integrins: signaling, disease, and therapy. Int. J. Radiat. Biol. 2007, 83, 743–751.
Cai, W.; Chen, X. Anti-angiogenic cancer therapy based on integrin αvβ3 antagonism. Anticancer Agents Med. Chem. 2006, 6, 407–428.
Wallbrunn, A.; Höltke, C.; Zühlsdorf, M.; Heindel, W.; Schäfers, M.; Bremer, C. In vivo imaging of integrin αvβ3 expression using fluorescence-mediated tomography. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 745–754.
Humphries, J. D.; Byron, A.; Humphries, M. J. Integrin ligands at a glance. J. Cell. Sci. 2006, 119, 3901–3903.
Haubner, R.; Bruchertseifer, F.; Bock, M.; Kessler, H.; Schwaiger, M.; Wester, H.-J. Synthesis and biological evaluation of a Tc-labelled cyclic RGD peptide for imaging the αvβ3 expression. Nuklearmed-Nucl med 2004, 43, 26–32.
Jiang, M.; Wu, J.; Liu, W.; Ren, H.; Zhang, W.; Lee, C. S.; Wang, P. Self-assembly of amphiphilic porphyrins to construct nanoparticles for highly efficient photodynamic therapy. Chem. Eur. J. 2021, 27, 11195–11204.
Ragàs, X.; Jiménez-Banzo, A.; Sánchez-García, D.; Batllori, X.; Nonell, S. Singlet oxygen photosensitisation by the fluorescent probe Singlet Oxygen Sensor Green®. Chem. Commun. 2009, 2920–2922.
Merlin, J.; Azzi, S.; Lignon, D.; Ramacci, C.; Zeghari, N.; Guillemin, F. MTT assays allow quick and reliable measurement of the response of human tumor cells to photodynamic therapy. Eur. J. Cancer 1992, 28, 1452–1458.
Cai, X.; Bandla, A.; Chuan, C. K.; Magarajah, G.; Liao, L. D.; Teh, D. B. L.; Kennedy, B. K.; Thakor, N. V.; Liu, B. Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient in vivo fluorescence image-guided photothermal therapy. Mater. Horiz. 2019, 6, 311–317.
Acknowledgments
This work was financially supported by the National Natural Science Foundation of China (Nos. 21873110 and 61720106014) and the Instrument Developing Project of the Chinese Academy of Sciences (No. YJKYYQ20170015).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Notes
The authors declare no competing financial interest.
Electronic Supplementary Information
Rights and permissions
About this article
Cite this article
Jiang, MY., Wu, JS., Liu, WM. et al. Porphyrin-based Nanosonosensitizers Combined with Targeting Peptides for Sonodynamic Therapy of Glioma. Chin J Polym Sci 40, 1120–1128 (2022). https://doi.org/10.1007/s10118-022-2795-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10118-022-2795-0